Literature DB >> 8416206

Fundal atrophic gastritis as a risk factor for gastric cancer.

M Tatsuta1, H Iishi, A Nakaizumi, S Okuda, H Taniguchi, T Hiyama, H Tsukuma, A Oshima.   

Abstract

The role of atrophic gastritis of the gastric corpus (fundal atrophic gastritis) as a high-risk factor was investigated by studying operative findings and follow-up data on 690 patients with benign gastric diseases recorded at the Osaka Cancer Registry. The extent of fundal atrophic gastritis was determined by the endoscopic Congo red test. The patients were followed-up from the time of endoscopic examination (1968 to 1976) to December 31, 1987. The vital status of 654 patients (94.8%) at the end of the observation period was determined. During the follow-up period, 22 patients were found to have gastric cancer. The extent of fundal atrophic gastritis was shown to be closely related with the risk of developing gastric cancer. Patients who had been diagnosed as having severe fundal atrophic gastritis showed significantly higher risk of gastric cancer than patients who had been diagnosed as having little or no fundal atrophic gastritis (5.76-fold, calculated with adjustments for age, sex and the follow-up period). A positive linear relationship was found between the risk of developing gastric cancer and the extent of fundal atrophic gastritis. The observed number of gastric cancers was compared with the expected number calculated from the incidence in Osaka Prefecture. Analysis of the results showed that the observed and expected numbers of gastric cancers in patients with severe fundal atrophic gastritis were 11 and 4.8, respectively, the ratio of observed to expected numbers being 2.3 (p < 0.05). These findings indicate that severe fundal atrophic gastritis is a major risk factor for gastric cancer.

Entities:  

Mesh:

Year:  1993        PMID: 8416206     DOI: 10.1002/ijc.2910530114

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  23 in total

1.  Chromoendoscopic evaluation of gastric mucosa after partial gastrectomy by use of modified endoscopic Congo red test.

Authors:  Ervin Tóth; Kristina Sjölund; Henrik Thorlacius
Journal:  World J Surg       Date:  2003-05-13       Impact factor: 3.352

2.  Gastric atrophy and xanthelasma are markers for predicting the development of early gastric cancer.

Authors:  Akira Sekikawa; Hirokazu Fukui; Ryota Sada; Manabu Fukuhara; Saiko Marui; Gensho Tanke; Masatsugu Endo; Yoshiaki Ohara; Fumihiro Matsuda; Jun Nakajima; Shinichiro Henmi; Sumio Saito; Takehiko Tsumura; Takanori Maruo; Toru Kimura; Yukio Osaki
Journal:  J Gastroenterol       Date:  2015-04-23       Impact factor: 7.527

3.  Validation of the pepsinogen test method for gastric cancer screening using a follow-up study.

Authors:  Shigeto Mizuno; Masao Kobayashi; Shohken Tomita; Ikuya Miki; Atsuhiro Masuda; Mitsuko Onoyama; Yasuki Habu; Hideto Inokuchi; Yoshiyuki Watanabe
Journal:  Gastric Cancer       Date:  2009-11-05       Impact factor: 7.370

4.  Serum pepsinogen and gastrin-17 as potential biomarkers for pre-malignant lesions in the gastric corpus.

Authors:  Tan Han Loong; Ngiu Chai Soon; Nik Ritza Kosai Nik Mahmud; Jeevinesh Naidu; Rafiz Abdul Rani; Nazefah Abdul Hamid; Marjanu Hikmah Elias; Isa Mohamed Rose; Azmi Tamil; Norfilza M Mokhtar; Raja Affendi Raja Ali
Journal:  Biomed Rep       Date:  2017-09-20

5.  Helicobacter pylori infection and gastric cancer. A nested case-control study in a rural area of Japan.

Authors:  Y Watanabe; J H Kurata; S Mizuno; M Mukai; H Inokuchi; K Miki; K Ozasa; K Kawai
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

6.  Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole.

Authors:  A E Berstad; J G Hatlebakk; H Maartmann-Moe; A Berstad; P Brandtzaeg
Journal:  Gut       Date:  1997-12       Impact factor: 23.059

7.  Time trends in the incidence of esophageal adenocarcinoma, gastric adenocarcinoma, and superficial esophagogastric junction adenocarcinoma.

Authors:  Kenshi Matsuno; Ryu Ishihara; Masayasu Ohmori; Hiroyoshi Iwagami; Satoki Shichijyo; Akira Maekawa; Takashi Kanesaka; Sachiko Yamamoto; Yoji Takeuchi; Koji Higashino; Noriya Uedo; Takashi Matsunaga; Toshitaka Morishima; Isao Miyashiro
Journal:  J Gastroenterol       Date:  2019-03-29       Impact factor: 7.527

8.  Prescreening of a high-risk group for gastric cancer by serologically determined Helicobacter pylori infection and atrophic gastritis.

Authors:  Shigeto Mizuno; Ikuya Miki; Tsukasa Ishida; Masaru Yoshida; Mitsuko Onoyama; Takeshi Azuma; Yasuki Habu; Hideto Inokuchi; Kotaro Ozasa; Kazumasa Miki; Yoshiyuki Watanabe
Journal:  Dig Dis Sci       Date:  2010-03-04       Impact factor: 3.199

Review 9.  Gastrin May Mediate the Carcinogenic Effect of Helicobacter pylori Infection of the Stomach.

Authors:  Helge L Waldum; Øyvind Hauso; Øystein F Sørdal; Reidar Fossmark
Journal:  Dig Dis Sci       Date:  2014-12-06       Impact factor: 3.199

10.  Autofluorescence imaging videoendoscopy in the diagnosis of chronic atrophic fundal gastritis.

Authors:  Takuya Inoue; Noriya Uedo; Ryu Ishihara; Tsukasa Kawaguchi; Natsuko Kawada; Rika Chatani; Takashi Kizu; Chie Tamai; Yoji Takeuchi; Koji Higashino; Hiroyasu Iishi; Masaharu Tatsuta; Yasuhiko Tomita; Ervin Tóth
Journal:  J Gastroenterol       Date:  2009-10-30       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.